Dr. Panoskaltsis' main laboratory research interests are in the immune pathogenesis of acute myeloid leukemia, in using bio-inspired three-dimensional (3D) ex vivo models to study normal and malignant hematopoiesis, and in creating novel precision immunochemotherapeutics using mathematical modeling and ex vivo 3D perfusion bioreactor culture systems. Her clinical research and clinical trials experience has spanned over 20 years during which time she has been the principal investigator for numerous clinical trials, mainly in the area of myeloid malignancies.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811